Most recently, Veralox Therapeutics raised $24.0M in its Early Stage VC (Jun 2023).
- ·The complete investor list: 15 names
- ·Watch Veralox Therapeutics: the Monday email on marks, rounds and moves
Veralox Therapeutics round by round
3 roundsHow much has Veralox Therapeutics raised?
Veralox Therapeutics has raised $41.2 million across 3 recorded rounds since 2019. The largest was a $24 million early-stage round in Jun 2023.
Veralox Therapeutics has filed 3 Form Ds with the SEC since 2019, most recently in Jun 2023 ($24 million sold to 14 investors).
Veralox Therapeutics investors
15 investors are on record for Veralox Therapeutics, including Alumni Ventures, Alexandria Venture Investments, TEDCO and NYBC Ventures. The early-stage round in Jun 2023 drew 14 investors.
15 investors have backed Veralox Therapeutics.
Frequently asked about Veralox Therapeutics
- How much has Veralox Therapeutics raised?
- Veralox Therapeutics has raised $41.2M in total across 3 recorded funding rounds.
- When was Veralox Therapeutics's last funding round?
- Veralox Therapeutics's most recent recorded round was Early Stage VC in Jun 2023, raising $24.0M.